BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Molecular Imaging for the Improved Visualization and Treatment of 
 Cancer - Jason Lewis\, MSKCC
DTSTART:20210121T130000Z
DTEND:20210121T140000Z
UID:TALK151573@talks.cam.ac.uk
CONTACT:Kate Davenport
DESCRIPTION:The use of Positron Emission Tomography (PET) for cancer imagi
 ng is a well-established and widely used molecular imaging modality both i
 n clinical and research settings. PET offers the ability to quantitatively
  measure biological and receptor-based processes using a wide spectrum of 
 specifically designed radiopharmaceuticals. The use of PET is expanding an
 d the inclusion of longer-lived radiometal positron-emitters is broadening
  the application and appeal of this imaging modality. The remarkable speci
 ficity and selectivity of antibodies for cancer biomarkers have made immun
 oglobulins some of the most flexible and adaptable tools in modern medicin
 e. For therapeutic purposes\, a wide range of non-labeled antibodies has n
 ow entered the clinic. Antibody-based PET and SPECT imaging agents are not
  far behind. For example\, an array of 89Zr-labeled radioimmunoconjugates 
 has shown significant promise in both preclinical and clinical studies. Th
 is presentation will discuss the clinical deployment of radiolabeled antib
 odies for both imaging and endoradiotherapy of cancer.
LOCATION:On Zoom please join at https://zoom.us/j/98710548470?pwd=TVZoNExQ
 c2ZNNE9VV0o0M2JFR1pLdz09  Meeting ID: 987 1054 8470 Passcode: 631155
END:VEVENT
END:VCALENDAR